Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03716830 · ClinicalTrials.gov registry record · NA
Enhancing Acupuncture Treatment Effect Through Non-invasive Neuromodulation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT03716830: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03716830 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03716830, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
In this study, investigators will examine the brain mechanism behind the synergistic effects of combining acupuncture and transcranial direct current stimulation (tDCS) treatments. Specifically, chronic low back pain (cLBP) patients will be recruited and randomized to one of four groups (30 per group, one month of treatment): 1) verum acupuncture + real tDCS, 2) sham acupuncture + real tDCS, 3) verum acupuncture + sham tDCS, and 4) sham acupuncture + sham tDCS. Investigators will study 1) the longitudinal (one-month) effects of different treatments as indicated by changes in resting state functional connectivity (rsFC), cerebral blood flow (CBF), clinical outcomes of low back pain, and quantitative sensory test (QST) and 2) the association between these changes.
Interventions
- DEVICE sham tDCS
- DEVICE real tDCS
- DEVICE verum acupuncture
- DEVICE sham acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2020-11-07 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03716830
The ClinicalTrials.gov registry entry for NCT03716830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which sham tDCS is the first listed.
NCT03716830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03716830 about?
NCT03716830 is a clinical study titled "Enhancing Acupuncture Treatment Effect Through Non-invasive Neuromodulation". In this study, investigators will examine the brain mechanism behind the synergistic effects of combining acupuncture and transcranial direct current stimulation (tDCS) treatments. Specifically, chronic low back pain (cLBP) patients will be recruited and randomized to one of four groups (30 per grou...
What is the current status of trial NCT03716830?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2020-11-07. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT03716830?
The interventions under investigation include: sham tDCS (DEVICE), real tDCS (DEVICE), verum acupuncture (DEVICE), sham acupuncture (DEVICE).
Who is sponsoring clinical trial NCT03716830?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.